- The presenter, Dr. Roy-Chaudhury said, “These results give the nephrology community a strong reason to rethink our approach to access decisions for women and, once approved by the FDA, to consider the ATEV as a meaningful new option.”
The annual Inc. Power Partner Awards recognizes B2B companies that provide essential services and expertise to help entrepreneurs and businesses grow The annual Inc. Power Partner Awards recognizes B2B companies that provide essential services and expertise to help entrepreneurs and businesses grow
BEND, Ore., Oct. 23, 2026 -- BranchOut Food Inc. (Nasdaq: BOF) (“BranchOut” or the “Company”), a growth-stage consumer packaged foods company focused on developing, manufacturing, marketing and distributing clean-label, plant-based dried fruit and vegetable snacks, today announced the pricing of an underwritten public offering of 2,941,177 shares of its common stock at a public offering price of $1.70 per share (the “Offering”). Gross proceeds to the Company, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $5.0 million. All of the shares in the Offering are to be sold by the Company.
A 1,500 MW Combined Renewable Natural Gas and Biomass Power Plant and Water Supply Project Valued at Up to $1.66 Billion; Azure Holds a 10% Equity Stake
Fiserv announced that Raj Seshadri will join the Fiserv Board of Directors effective November 30, 2026.
Preclinical data demonstrate tumor response with AVA6103 in the setting of Enhertu®-resistance
Amogy announced that it will deploy its ammonia cracking technology with Singapore's lead public sector R&D agency, A*STAR.
3 E Network Announces Entry into Material Definitive Agreement, Related Party Transaction and Unregistered Sale of Equity Securities
JK06 continued to demonstrate a highly differentiated safety profile for an MMAE ADC among 230 patients in the target dose range; predominantly low-grade, manageable treatment-related adverse events (TRAEs) were observed with low rates of dose reduction and discontinuation Among response-evaluable squamous non-small cell
HARRISBURG, Pa., October 23, 2026--K2 Insurance Services announced today that its subsidiary, Aegis General Insurance Agency , will wind down its Executive Risks Division. The division will stop writing new and renewal business effective November 1, 2026. The decision follows a strategic review of the
CHESTER, Conn., October 23, 2026--Energea, a U.S.-based investment platform that manages energy infrastructure portfolios, today announced that it is expanding its U.S. portfolio beyond solar investments to include electric vehicle (EV) charging investments. Energea Portfolio 4 USA LP ("the Portfolio")
SANTA CLARA, Calif., October 23, 2026--Oklo Inc. (NYSE: OKLO) ("Oklo," or "the Company"), an advanced nuclear technology company, today announced it will release its financial results and provide business updates for the third quarter ended September 30, 2026, before market opens on Friday, November 6,